The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis

References

• Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, et al. 2020. NCCN guidelines insights: cervical cancer, version 1.2020. Journal of the National Comprehensive Cancer Network 18:660–666.
   PubMed Web of Science ®Google Scholar
• Allegra C, Sargent DJ. 2005. Adjuvant therapy for colon cancer – the pace quickens. The New England Journal of Medicine 352:2746–2748.
   PubMed Web of Science ®Google Scholar
• Arriagada R, Bergman B, Dunant A, Le CT, Pignon JP, Vansteenkiste J. 2004. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. New England Journal of Medicine 350:351–360.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians 68:394–424.
   PubMed Web of Science ®Google Scholar
• Choi CH, Lee YY, Kim MK, Kim TJ, Lee JW, Nam HR, et al. 2011. A matched-case comparison to explore the role of consolidation chemotherapy after concurrent chemoradiation in cervical cancer. International Journal of Radiation Oncology, Biology, Physics 81:1252–1257.
   PubMed Web of Science ®Google Scholar
• Dueñas-González A, Zarbá JJ, Patel F, Alcedo JC, Beslija S, Casanova L, et al. 2011. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. Journal of Clinical Oncology 29:1678–1685.
   PubMed Web of Science ®Google Scholar
• Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. 2004. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Journal of Clinical Oncology 22:872–880.
   PubMed Web of Science ®Google Scholar
• Fabri VA, Queiroz ACM, Mantoan H, Sanches SM, Guimarães APG, Ribeiro ARG, et al. 2019. The impact of addition of consolidation chemotherapy to standard cisplatin-based chemoradiotherapy in uterine cervical cancer: matter of distant relapse. Journal of Oncology 2019:1217838.
   PubMed Web of Science ®Google Scholar
• Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, et al. 1999. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New England Journal of Medicine 340:1154–1161.
   PubMed Web of Science ®Google Scholar
• Kim HS, Kim MK, Kim HJ, Han SS, Kim JW. 2012. Phase II study of consolidation chemotherapy after adjuvant or primary concurrent chemoradiation using paclitaxel and carboplatin to treat high-risk early-stage or locally advanced cervical cancer. Cancer Research and Treatment 44:97–103.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Lee KJ, Park KR, Kim J, Jung W, Lee R, et al. 2015. Prognostic analysis of uterine cervical cancer treated with postoperative radiotherapy: importance of positive or close parametrial resection margin. Radiation Oncology Journal 33:109–116.
   PubMedGoogle Scholar
• Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. 1999. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. New England Journal of Medicine 340:1137–1143.
   PubMed Web of Science ®Google Scholar
• Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, et al. 2000. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Journal of Clinical Oncology 18:1606–1613.
   PubMed Web of Science ®Google Scholar
• Rose PG. 2002. Chemoradiotherapy for cervical cancer. European Journal of Cancer 38:270–278.
   PubMed Web of Science ®Google Scholar
• Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. 1999. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New England Journal of Medicine 340:1144–1153.
   PubMed Web of Science ®Google Scholar
• Sun W, Wang T, Shi F, Wang J, Wang J, Hui B, et al. 2015. Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy. BMC Cancer 15:353.
   PubMed Web of Science ®Google Scholar
• Tang J, Tang Y, Yang J, Huang S. 2012. Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma. Gynecologic Oncology 125:297–302.
   PubMed Web of Science ®Google Scholar
• Vrdoljak E, Hamm W, Omrcen T, Prskalo T. 2004. Long-lasting complete remission of a patient with cervical cancer FIGO IVB treated by concomitant chemobrachyradiotherapy with ifosfamide and cisplatin and consolidation chemotherapy–a case report. European Journal of Gynaecological Oncology 25:247–249.
   PubMed Web of Science ®Google Scholar
• Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, et al. 1999. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. Journal of Clinical Oncology 17:1339–1348.
   PubMed Web of Science ®Google Scholar